Exposure to Potentially Harmful Drug-Disease Interactions in Older Community-Dwelling Veterans Based on the Healthcare Effectiveness Data and Information Set Quality Measure: Who Is at Risk?

• Autores: Mary Jo Pugh, Catherine I. Starner, Megan E. Amuan, Dan R. Berlowitz, Monica S. Horton, Zachary A. Marcum, Joseph T. Hanlon
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 59, Nº. 9, 2011, págs. 1673-1678
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • OBJECTIVES: To identify prevalence and risk factors for exposure to drug�disease interactions included in the Healthcare Effectiveness Data and Information Set (HEDIS) Drug�Disease Interaction (Rx-DIS) measure.

    DESIGN: Cross-sectional retrospective database analysis.

    SETTING: Outpatient clinics within the Department of Veterans Affairs (VA).

    PARTICIPANTS: Individuals aged 65 and older who received VA outpatient care between October 1, 2003, and September 30, 2006.

    MEASUREMENTS: Rx-DIS exposure based on the HEDIS measure was identified in VA patients with dementia, falls, and chronic renal failure using VA pharmacy and administrative databases. Factors associated with Rx-DIS exposure were examined, including demographic, health status, and access-to-care factors, including VA outpatient health services use and copayment status.

    RESULTS: Of the 305,041 older veterans who met criteria for inclusion, the 1-year prevalence of Rx-DIS exposure was 15.2%; prevalence was 20.2% for dementia, 16.2% for falls, and 8.5% for chronic renal failure. Patients with high disease burden (physical, psychiatric, number of medications) were significantly more likely to have Rx-DIS exposure, regardless of condition. Hispanics and individuals with no copayments were more likely to have Rx-DIS exposure than whites or those with required copayments. There was variation in other predictors based on the type of Rx-DIS.

    CONCLUSION: The prevalence of Rx-DIS was common in older VA outpatients. Future studies should examine the risk of Rx-DIS exposure on health outcomes using separate analyses for each type of Rx-DIS separately before combining all Rx-DIS into a single measure of exposure. Studies that examine the effectiveness of interventions to reduce Rx-DIS exposure will also be helpful in improving the quality of care for older adults.